Comparative efficacy of continuous versus intermittent administration of furosemide in acute heart failure: an updated systematic review and meta-analysis of 22 RCTs - Report - MDSpire
Advertisement
Comparative efficacy of continuous versus intermittent administration of furosemide in acute heart failure: an updated systematic review and meta-analysis of 22 RCTs
Efficacy Comparison of Continuous versus Intermittent Furosemide Administration in Acute Heart Failure
Overview
This systematic review and meta-analysis of 22 RCTs evaluates the efficacy of continuous versus intermittent furosemide administration in acute heart failure. Continuous infusion was associated with improvements in freedom from congestion and weight loss, while no significant advantage was found for all-cause mortality.
Background
Acute heart failure (AHF) is a leading cause of hospitalization worldwide, with a significant burden on healthcare systems. The optimal administration strategy for loop diuretics, particularly furosemide, remains debated. Understanding the efficacy of different administration methods is essential.
Data Highlights
Outcome
Continuous Infusion (cIV)
Intermittent Infusion (iIV)
Evidence Quality
All-cause mortality
RR: 1.36
RR: 1.00
Low
Freedom from congestion
RR: 1.42
RR: 1.00
Moderate
Weight loss
Significant improvement
No significant improvement
Moderate
24-h urine volume
Significant improvement
No significant improvement
Low
Length of hospital stay
Significant improvement
No significant improvement
Low
Key Findings
The cIV arm showed improvements in freedom from congestion (RR: 1.42, p = 0.02).
Intermittent infusion showed a numerical trend toward higher all-cause mortality (RR: 1.36, p = 0.08) without statistical significance.
Continuous infusion resulted in greater weight loss compared to intermittent infusion.
Continuous infusion was associated with higher 24-h urine volume and shorter length of hospital stay.
Post-treatment BNP levels were lower in the cIV group.
Clinical Implications
The findings suggest that continuous furosemide infusion may provide better management of congestion and fluid overload in acute heart failure patients. Clinicians should consider the potential benefits of continuous infusion when developing treatment plans for patients with AHF.
Conclusion
Continuous furosemide infusion demonstrates advantages in managing acute heart failure in terms of congestion relief and weight loss, although no significant impact on long-term survival was observed.